In this podcast, Rakesh Jain, MD, MPH, examines the similarities and differences between the 2 medications approved by the US Food and Drug Administration for the treatment of tardive dyskinesia.
In this podcast, Rakesh Jain, MD, MPH, examines the similarities and differences between the 2 medications approved by the US Food and Drug Administration for the treatment of tardive dyskinesia.
Listen to a discussion on the importance of sleep in the production of body homeostasis and the glymphatic system's ability to drain buildup of toxins in the brain.
Listen to a discussion on the importance of sleep in the production of body homeostasis and the glymphatic system's ability to drain buildup of toxins in the brain.
In this episode, Rachel Marie E. Salas, MD, MEd, continues her conversation with C. Debbie Lin, MD, discussing some of the major challenges in neurology private practice, balancing work with other aspects of her life, and the career advice...
In this episode, Rachel Marie E. Salas, MD, MEd, continues her conversation with C. Debbie Lin, MD, discussing some of the major challenges in neurology private practice, balancing work with other aspects of her life, and the career advice...
In this episode, Rachel Marie E. Salas, MD, MEd, talks with with C. Debbie Lin, MD, to discuss why she pursued private practice and the excitement she finds in practicing as a general neurologist.
In this episode, Rachel Marie E. Salas, MD, MEd, talks with with C. Debbie Lin, MD, to discuss why she pursued private practice and the excitement she finds in practicing as a general neurologist.
In this episode, Rachel Marie E. Salas, MD, MEd, continues her conversation with Mark J. Milstein, MD, FAAN, to discuss how he discovered his interest in medical education and future trends in neurology training.
In this episode, Rachel Marie E. Salas, MD, MEd, continues her conversation with Mark J. Milstein, MD, FAAN, to discuss how he discovered his interest in medical education and future trends in neurology training.
In this episode, Rachel Marie E. Salas, MD, MEd, wraps up her conversation with Mark J. Milstein, MD, FAAN, with details on his advocacy work through the American Medical Association and the American Academy of Neurology, and how neurologists...
In this episode, Rachel Marie E. Salas, MD, MEd, wraps up her conversation with Mark J. Milstein, MD, FAAN, with details on his advocacy work through the American Medical Association and the American Academy of Neurology, and how neurologists...
In this episode, Rachel Marie E. Salas, MD, MEd, talks with Mark J. Milstein, MD, FAAN, to discuss his hybrid clinical work as a neurohospitalist and neuromuscular specialist at Montefiore Medical Center in the Bronx, New York.
In this episode, Rachel Marie E. Salas, MD, MEd, talks with Mark J. Milstein, MD, FAAN, to discuss his hybrid clinical work as a neurohospitalist and neuromuscular specialist at Montefiore Medical Center in the Bronx, New York.
In this episode, Rachel Marie E. Salas, MD, MEd, continues her conversation with Madhu Mona Soni, MD, FAAN, to discuss future trends in neurology, wellness in the workplace, and telehealth.
In this episode, Rachel Marie E. Salas, MD, MEd, continues her conversation with Madhu Mona Soni, MD, FAAN, to discuss future trends in neurology, wellness in the workplace, and telehealth.
In this episode, Dr Rachel Salas, MD, MEd, sits down with Madhu Mona Soni, MD, FAAN, to discuss exciting developments in neuromuscular neurology, the power of interdisciplinary patient care, and more!
In this episode, Dr Rachel Salas, MD, MEd, sits down with Madhu Mona Soni, MD, FAAN, to discuss exciting developments in neuromuscular neurology, the power of interdisciplinary patient care, and more!
In this episode, Rachel Marie E. Salas, MD, MEd, interviews Marie Eugene, DO, about her work in medical education and training, what being an epilepsy specialist involves, and new developments in epileptology.
In this episode, Rachel Marie E. Salas, MD, MEd, interviews Marie Eugene, DO, about her work in medical education and training, what being an epilepsy specialist involves, and new developments in epileptology.
Patients with MS had about half the rate of amyloid pathology compared with matched control subjects in the Washington University School of Medicine study.
Patients with MS had about half the rate of amyloid pathology compared with matched control subjects in the Washington University School of Medicine study.
Suvorexant, a sleep-promoting orexin receptor antagonist, was associated with lower rates of delirium than placebo in hospitalized older adults at high risk of delirium, but the difference was not statistically significant.
Suvorexant, a sleep-promoting orexin receptor antagonist, was associated with lower rates of delirium than placebo in hospitalized older adults at high risk of delirium, but the difference was not statistically significant.
A new cohort study involving female participants found no link between migraine and later Parkinson disease (PD) development. Findings from the study were published in Neurology.
A new cohort study involving female participants found no link between migraine and later Parkinson disease (PD) development. Findings from the study were published in Neurology.
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
Dementia occurrence in Parkinson disease (PD) may occur less frequently or take more time to develop than previous studies have shown, according to recent results from 2 ongoing prospective studies published in Neurology.
Dementia occurrence in Parkinson disease (PD) may occur less frequently or take more time to develop than previous studies have shown, according to recent results from 2 ongoing prospective studies published in Neurology.
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Collaborative dementia care management (CDCM) was associated with improved patient and caregiver outcomes over 3 years after the initial care period, according to results from a randomized controlled trial published in JAMA Network Open. U
Collaborative dementia care management (CDCM) was associated with improved patient and caregiver outcomes over 3 years after the initial care period, according to results from a randomized controlled trial published in JAMA Network Open. U
Combined physiotherapy and psychotherapy improved symptoms and physical aspects of quality of life in patients with functional movement disorders more than psychological support alone, according to study results published in JAMA Neurology.
Combined physiotherapy and psychotherapy improved symptoms and physical aspects of quality of life in patients with functional movement disorders more than psychological support alone, according to study results published in JAMA Neurology.
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
To view accreditation information/faculty disclosures for the program, click
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
To view accreditation information/faculty disclosures for the program, click
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
To view accreditation information/faculty disclosures for the program, click
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
To view accreditation information/faculty disclosures for the program, click